EGF and atrial fibrillation: The ability to classify patients as having source‐dependent AF (S‐type EGF signature) versus source‐independent AF (C‐type EGF signature) may prove clinically useful for stratifying persistent and long‐standing persistent AF patients that will benefit from PVI alone and those that will require PVI in addition to targeted extra‐PV ablation.